Company: CNTB
Filing Date: 2025-06-10
Form Type: S-8
Source: 0001193125-25-138485
Chunk: 4

Company: Connect Biopharma Holdings Ltd
Filing Date: 2025-06-10
Form: S-8
Chunk 4
---
                                  
 Biopharma Holdings Limited, the depositary, and the holders and beneficial owners of American Depositary Shares issued thereunder |     | S-8                        |     | 333-254524 |     |       4.3 |     | 3/19/2021   |     |           |
| 5.1     |     | Opinion of Maples and Calder (Hong Kong) LLP regarding the validity of the ordinary shares being registered                       |     |                            |     |            |     |           |     |             |     | Filed     |
| 10.1    |     | 2021 Stock Incentive Plan                                                                                                         |     | F-1/A                      |     | 333-253631 |     |      10.3 |     | 3/12/2021   |     |           |
| 10.2    |     | 2024 Employment Inducement Incentive Award Plan                                                                                   |     |                            |     |            |     |           |     |             |     | Filed     |
| 23.1    |     | Consent of Independent Registered Public Accounting Firm                                                                          |     |                            |     |            |     |           |     |             |     | Filed     |
| 23.2    |     | Consent of Maples and Calder (Hong Kong) LLP (included in Exhibit 5.1)                                                            |     |                            |     |            |     |           |     |             |     | Filed     |
| 24.1    |     | Power of Attorney (included on the signature page of this report)                                                                 |     |                            |     |            |     |           |     |             |     | Filed     |
| 107     |     | Calculation of Filing Fee Table                                                                                                   |     |                            |     |            |     |           |     |             |     | Filed     |

Item 9. Undertakings.

| (a) | The undersigned Registrant hereby undertakes: |

| (1) | To file, during any period in which offers or sales are being made, a post-effective amendment to this 
 Registration Statement:                                                                                |

| (i) | to include any prospectus required by section 10(a)(3) of the Securities Act; |

| (ii) | to reflect in the prospectus any facts or events arising after the effective date of the registration                                                                                                                                                    
 statement (or the most recent post-effective amendment thereof) which,